Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.
about
Changes in malaria burden and transmission in sentinel sites after the roll-out of long-lasting insecticidal nets in Papua New GuineaPlasmodium vivax Controlled Human Malaria Infection - Progress and ProspectsMalaria modeling: In vitro stem cells vs in vivo modelsNew developments in anti-malarial target candidate and product profilesA high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings.Plasmodium vivax sporozoite challenge in malaria-naïve and semi-immune Colombian volunteersDevelopment of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines.Blood-Stage Parasitaemia and Age Determine Plasmodium falciparum and P. vivax Gametocytaemia in Papua New Guinea.Mosquitoes Reset Malaria ParasitesGametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy.Sensitive Detection of Plasmodium vivax Using a High-Throughput, Colourimetric Loop Mediated Isothermal Amplification (HtLAMP) Platform: A Potential Novel Tool for Malaria Elimination.Analysis of Breath Specimens for Biomarkers of Plasmodium falciparum Infection.Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria TransmissionPlasmodium vivax but Not Plasmodium falciparum Blood-Stage Infection in Humans Is Associated with the Expansion of a CD8+ T Cell Population with Cytotoxic Potential.Recent advances in recombinant protein-based malaria vaccines.Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trialDemonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01Infectivity of Plasmodium falciparum in Malaria-Naive Individuals Is Related to Knob Expression and Cytoadherence of the Parasite.Key Knowledge Gaps for Plasmodium vivax Control and EliminationEarly Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c+ Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell Activation.Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum.Controlled Human Malaria Infection: Applications, Advances and Challenges.malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication.malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication.Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection‡.Integrative metabolomics and transcriptomics signatures of clinical tolerance to Plasmodium vivax reveal activation of innate cell immunity and T cell signaling.A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.Bone Marrow Is a Major Parasite Reservoir in Plasmodium vivax Infection.Acceptability of a herd immunity-focused, transmission-blocking malaria vaccine in malaria-endemic communities in the Peruvian Amazon: an exploratory study.MalariaDevelopment of medicines for the control and elimination of malaria
P2860
Q26315315-3A90E8F7-F82F-430F-B64C-61A4919D5EE1Q28066456-0C5B5591-D237-452A-BC22-D5E346690CD8Q28071293-1A01EF9A-9D41-442D-BC58-87ABDA04E23EQ28468598-C9161CBE-82E9-4DA6-BAD6-3572D092A633Q28539392-FC67E271-6B20-409E-8456-215393A5B9F7Q28539992-2970B697-64C2-4EDA-8EF3-1E668AF3A6AFQ35354508-A3601FD2-8CD2-4A90-B07F-4C9B239EF8C8Q35634399-5BD5B6AF-D885-42D4-B7B1-C2543548541AQ35680345-386B0915-9D84-44B0-AF3D-9A6091BF3541Q35860086-33EEDAD9-6A19-4358-8DAA-F3F6FEE3851BQ35921902-6F5ECB01-A512-4EAF-9EAB-2C15AC3E0CA4Q36024472-CE4433C2-3890-4E99-A719-FDD63CF01C5CQ36215894-BD5C6462-00AC-440B-9D88-3F4C8242EF1AQ36215933-5C7075F2-C298-42F5-8E70-3E822CD8E8E3Q36394182-803ECA33-9C99-477C-827C-C77D207507BCQ36580228-5520BB87-C9F9-45BF-AB96-90730B5D5AA3Q36871970-8A0C701B-E1B1-4B64-A6FC-1A1411067AF1Q37199873-437756FD-F52B-4ABA-ADB7-2D8BBA87A14DQ37546198-27CAB498-EDB0-4CB9-8888-427C6D34034BQ38892525-ABDE37C7-EF20-4ED7-8C6B-261558ABB98EQ39571844-98F3443D-DAC3-4348-BFB7-179E0BB83E8CQ44168331-ED37DA01-8BCD-42D7-AEE1-F9EC4E0699ADQ47134819-6AA39CFD-14BD-4549-88EE-2723ED80E9C8Q47162062-89CB0C32-E5E4-4795-960A-C5CC1BEDFE42Q50281824-717050EF-6E26-4F99-823E-D5B274D37DEFQ52308706-5C3E2560-DB37-419B-9DB0-E3FDC878A16EQ54216698-E15CB001-0E6D-4D12-88A6-ECFF37939D7AQ54217777-93972F9D-97AE-4639-B222-924F4631CF6CQ55104120-17C4FDF2-4A62-4CF1-9C01-FBCF430E509DQ56378965-574149FC-3C0D-4651-ABB5-429BFA6FC6BBQ57019124-366263E0-C83E-4EAD-85CA-C485EF5E7584
P2860
Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.
@en
Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.
@nl
type
label
Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.
@en
Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.
@nl
prefLabel
Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.
@en
Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.
@nl
P2093
P2860
P50
P356
P1476
Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers
@en
P2093
A Taylor Bright
David Looke
Katharine R Trenholme
Rebecca Rockett
Silvana Sekuloski
Suzanne Elliott
Theo Sloots
P2860
P304
P356
10.1093/INFDIS/JIT394
P407
P577
2013-08-01T00:00:00Z